Floatz logo

209 assets in Breast Carcinoma

Therapeutic assets addressing Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
[177lu]lu-nns309
Breast Carcinoma
Novartis PharmaceuticalsP1CC (43)
[68Ga]Ga-NNS309
Breast Carcinoma
Novartis PharmaceuticalsP1CC (43)
68Ga-NNS309
Breast Carcinoma
Novartis PharmaceuticalsP1CC (43)
Bazedoxifene
Breast Carcinoma
Carol Fabian, MDEarly P1CC (43)
Berzosertib
Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Bl-M17D1
Breast Carcinoma
SystImmune Inc.P1CC (43)
c105
Breast Carcinoma
University of WashingtonP1CC (43)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine
Breast Carcinoma
University of WashingtonP1CC (43)
CD47/SIRPA-BLOCKING AGENT ALX148
Breast Carcinoma
QuantumLeap Healthcare CollaborativeP1CC (43)
Elimusertib
Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Estrogens, Conjugated
Breast Carcinoma
Carol Fabian, MDEarly P1CC (43)
Fam-Trastuzumab Deruxtecan-Nxki
Breast Carcinoma
QuantumLeap Healthcare CollaborativeP1CC (43)
hrs8807
Breast Carcinoma
Shanghai Hengrui Pharmaceutical Co., Ltd.P1CC (43)
nkt3447
Breast Carcinoma
NiKang Therapeutics, Inc.P1CC (43)
nkt3964
Breast Carcinoma
NiKang Therapeutics, Inc.P1CC (43)
Oncolytic Measles Virus Encoding Helicobacter Pylori Neutrophil-Activating Protein
Breast Carcinoma
Mayo ClinicP1CC (43)
Pidnarulex
Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Sry-Box Transcription Factor 2
Breast Carcinoma
University of WashingtonP1CC (43)
Vistusertib
Breast Carcinoma
M.D. Anderson Cancer CenterP1CC (43)
Yb-1
Breast Carcinoma
University of WashingtonP1CC (43)
Atv-1601
Breast Carcinoma
Atavistik Bio, IncP1CC (41)
Bet Bromodomain Inhibitor Zen-3694
Breast Carcinoma
National Cancer Institute (NCI)P1CC (41)
Cabozantinib
Breast Carcinoma
M.D. Anderson Cancer CenterP1CC (41)
Cdx 1140
Breast Carcinoma
University of Southern CaliforniaP1CC (41)
Copper Cu-64-Dota-Alendronate
Breast Carcinoma
City of Hope Medical CenterEarly P1CC (41)
Dostarlimab
Breast Carcinoma
University of WashingtonP1CC (41)
Efineptakin Alfa
Breast Carcinoma
National Cancer Institute (NCI)P1CC (41)
Mammaglobin-A Dna Vaccine
Breast Carcinoma
Washington University School of MedicineP1CC (41)
Nuv-868
Breast Carcinoma
Nuvation Bio Inc.P1CC (41)
Recombinant Flt3 Ligand
Breast Carcinoma
University of Southern CaliforniaP1CC (41)
Somatotropin (Ox), 127-L-Leucine-
Breast Carcinoma
German Cancer Research CenterP1CC (41)
Sulfur Hexafluoride
Breast Carcinoma
University of Southern CaliforniaP1CC (41)
Tocilizumab
Breast Carcinoma
University of Southern CaliforniaP1CC (41)
Alectinib
Breast Carcinoma
OHSU Knight Cancer InstituteEarly P1C (39)
Minoxidil
Breast Carcinoma
Ohio State University Comprehensive Cancer CenterEarly P1C (39)
[18F]SF-DEVD-2
Breast Carcinoma
Affiliated Hospital of Jiangnan UniversityEarly P1C (38)
18f-αvβ6-bp
Breast Carcinoma
Julie L. Sutcliffe, Ph.DEarly P1C (38)
Delta-8-Tetrahydrocannabinol
Breast Carcinoma
City of Hope Medical CenterEarly P1C (38)
Dihydrotestosterone
Breast Carcinoma
Memorial Sloan Kettering Cancer CenterEarly P1C (38)
(1R,3R)-N<sup>1</sup>-[5-(1-Ethylpropyl)pyrazolo[1,5-a]pyrimidin-7-yl]-1,3-cyclopentanediamine
Breast Carcinoma
Nuvation Bio Inc.P1/2C (32)
Abesili
Breast Carcinoma
Tianjin Medical University Cancer Institute and HospitalN/AD (30)
Calendula
Breast Carcinoma
OHSU Knight Cancer InstituteN/AD (30)
Enituzumab
Breast Carcinoma
Tianjin Medical University Cancer Institute and HospitalN/AD (30)
Granulocyte Colony-Stimulating Factor Lenograstim
Breast Carcinoma
Centre Georges Francois LeclercN/AD (30)
Hydrocortisone
Breast Carcinoma
OHSU Knight Cancer InstituteN/AD (30)
Soluble Fluorescein
Breast Carcinoma
Mayo ClinicN/AD (30)
Sulfadiazine
Breast Carcinoma
OHSU Knight Cancer InstituteN/AD (30)
White Button Mushroom Extract
Breast Carcinoma
City of Hope Medical CenterN/AD (30)
Trotabresib
Breast Carcinoma
Northwestern UniversityP1D (23)
Showing 151 to 200 of 209 assets
PreviousPage 4 of 5Next